INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 41 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,473,000 | +5.8% | 1,832,000 | -0.9% | 0.01% | -9.1% |
| Q2 2020 | $1,392,000 | -90.5% | 1,849,000 | -89.6% | 0.01% | -91.9% |
| Q1 2020 | $14,609,000 | -19.4% | 17,763,000 | -1.0% | 0.14% | +8.0% |
| Q4 2019 | $18,129,000 | -31.8% | 17,940,000 | -41.7% | 0.12% | -22.8% |
| Q3 2019 | $26,596,000 | +56.0% | 30,757,000 | +61.7% | 0.16% | +39.7% |
| Q2 2019 | $17,046,000 | -2.6% | 19,022,000 | +8.1% | 0.12% | -8.7% |
| Q1 2019 | $17,498,000 | +6.8% | 17,603,000 | -0.5% | 0.13% | -4.5% |
| Q4 2018 | $16,382,000 | -8.8% | 17,695,000 | -0.0% | 0.13% | -2.9% |
| Q3 2018 | $17,969,000 | +15.8% | 17,703,000 | +0.4% | 0.14% | +28.0% |
| Q2 2018 | $15,522,000 | +9.3% | 17,639,000 | +0.1% | 0.11% | +20.2% |
| Q1 2018 | $14,196,000 | -0.2% | 17,620,000 | -1.0% | 0.09% | -82.9% |
| Q4 2017 | $14,221,000 | +1.6% | 17,789,000 | -1.3% | 0.52% | -0.4% |
| Q3 2017 | $14,000,000 | -16.5% | 18,020,000 | +5.0% | 0.52% | -26.5% |
| Q2 2017 | $16,764,000 | +4.9% | 17,160,000 | +0.5% | 0.71% | -2.5% |
| Q1 2017 | $15,982,000 | +4.6% | 17,069,000 | +0.0% | 0.73% | -0.3% |
| Q4 2016 | $15,284,000 | -21.4% | 17,064,000 | -1.5% | 0.73% | -16.9% |
| Q3 2016 | $19,454,000 | – | 17,331,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|